Document Classification

Section Type: RESULTS

Text: The intention-to-treat eradication rates were 94. 7 % (95 % confidence interval (CI) = 88. 8-100 %, 54/57) in the antimicrobial susceptibility-guided group and 71. 9 % (95 % CI = 60. 2-83. 5 %, 41/57) in the clarithromycin-based triple therapy group after the initial treatment (P = 0. 002), whereas the per-protocol (PP) eradication rates were 96. 4 % (95 % CI = 91. 5-100 %, 54/56) in the antimicrobial susceptibility-guided group and 73. 2 % (95 % CI = 61. 5-84. 8 %, 41/56) in the clarithromycin-based triple therapy group (P = 0. 001).